- Home
- KZR vs ENLV Comparison
KZR vs ENLV Comparison
Compare KZR & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KZR | ENLV |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.7M | 26.6M |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | KZR | ENLV |
|---|---|---|
| Price | $6.25 | $1.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $6.00 | ★ $7.00 |
| AVG Volume (30 Days) | 35.4K | ★ 11.2M |
| Earning Date | 11-12-2025 | 11-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.53 | $0.83 |
| 52 Week High | $7.27 | $2.10 |
Technical Indicators
Market Signals| Indicator | KZR | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 64.26 | 62.72 |
| Support Level | $6.05 | $0.89 |
| Resistance Level | $6.29 | $1.06 |
| Average True Range (ATR) | 0.14 | 0.14 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 76.00 | 32.57 |
Price Performance
Historical ComparisonAbout KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.